Go Deep
iSpecimen Inc.
iSpecimen Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,972 | -0.0 | 1.49 | 0.14 | 97.56 |
| Oct 2026 | 23,070 | -0.0 | 1.33 | 0.14 | 86.85 |
| Oct 2026 | 20,476 | -0.0 | 1.32 | 0.14 | 86.29 |
| Oct 2026 | 20,433 | -0.0 | 1.39 | 0.14 | 91.01 |
| Oct 2026 | 20,491 | -0.0 | 1.29 | 0.14 | 84.41 |
| Oct 2026 | 20,543 | -0.0 | 1.21 | 0.14 | 78.60 |
iSpecimen Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 151,940.0 | 156,009.0 | 51,761.0 | 106,592.0 |
| Net Profit | -1,362,811.0 | -2,275,221.0 | -5,001,245.0 | -2,780,648.0 |
| EPS | -1.0 | -6.7 | — | -19.2 |
iSpecimen Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 1,928,998.0 | 9,291,115.0 | 9,928,184.0 | 10,402,303.0 | — |
| Net Profit | -10,487,532.0 | -12,497,805.0 | -11,099,488.0 | -10,245,922.0 | — |
| EPS | -91.2 | -703.2 | -982.0 | -928.0 | — |
iSpecimen Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 9,531,410.0 | 9,350,230.0 | 15,819,137.0 | 24,617,653.0 | — |
| Total Liabilities | 6,443,179.0 | 6,039,222.0 | 6,078,060.0 | 4,308,483.0 | — |
| Total Equity | 3,088,231.0 | 3,311,008.0 | 9,741,077.0 | 20,309,170.0 | — |
Owes vs Owns
iSpecimen Inc. owed $0.77 for every $1 it owned in Jun 2026, up from $0.18 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.77× | 0.68× | 0.65× | 0.38× | 0.18× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
iSpecimen Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 72.2%Receivables 0.5%Fixed assets (tangible) 3.1%Intangible assets 23.8%
How it's funded — Dec 2025
Short-term debt 0.6%Long-term debt 2.2%Payables 56.3%Other liabilities 8.5%Shareholders' equity 32.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.9 | 1.9 | 5.0 | 15.3 |
| Receivables | 0.0 | 1.4 | 2.9 | 4.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.3 | 0.4 | 0.3 | 0.4 |
| Intangible assets | 2.3 | 5.3 | 7.2 | 4.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.0 | 0.2 | 0.3 | 0.3 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.0 | 0.2 | 0.2 |
| Long-term debt | 0.2 | 0.3 | 0.0 | 0.0 |
| Payables | 5.4 | 4.2 | 3.9 | 2.5 |
| Other liabilities | 0.8 | 1.5 | 2.0 | 1.7 |
| Shareholders' equity | 3.1 | 3.3 | 9.7 | 20.3 |
| Net tangible assets | 0.8 | -2.0 | 2.5 | 15.8 |
iSpecimen Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -4,240,608.0 | -8,263,713.0 | -5,807,550.0 | -5,817,720.0 | — |
| Investing Activities | -1,000,454.0 | 1,979,554.0 | -7,228,383.0 | -3,191,190.0 | — |
| Financing Activities | 10,243,489.0 | 5,818,901.0 | 70,889.0 | -3,421,359.0 | — |